PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 1.72 million shares for the 12-month period ending 2017-07-31, per its 10-K filed 2018-10-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2018-10-25
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2017 was 1.72M shares, a 91.54% decline from fiscal 2016.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2016 was 20.38M shares, a 337.98% increase from fiscal 2015.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2015 was 4.65M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|
| 2017-07-31 | 1.72M shares 10-K · filed 2018-10-25 |
| 2016-07-31 | 20.38M shares 10-K · filed 2017-10-26 |
| 2015-07-31 | 4.65M shares 10-K · filed 2016-10-27 |